Lung Cancer - Small Cell


Edward S. Kim, M.D., FACP, reviews the key differences between small cell and non-small cell lung cancer.
View more at http://curetoday.com/
CURE: Combining science and humanity to make cancer understandable.


Learn more about lung cancer at http://www.YouAndLungCancer.com
This animation provides an overview of several immunotherapy treatments that have been approved for small cell lung cancer (SCLC). Immunotherapy is the use of medicines to stimulate the body's immune system to recognize and attack cancer cells. This animation also describes how your doctor will evaluate whether immunotherapy is right for you, possible treatment side effects, and clinical trials. It’s very important to report any side effects to your health care team promptly. Side effects of immunotherapy are often treated with drugs that suppress your immune system. Your immunotherapy will be stopped until the side effects clear up. Discuss all of your treatment options as with your health care team, so you can make decisions that are right for you. If there’s anything you don’t understand, ask to have it explained.


Learn more about lung cancer at http://www.YouAndLungCancer.com
This animation provides an overview of several immunotherapy treatments that have been approved for non-small cell lung cancer (NSCLC). Immunotherapy is the use of medicines to stimulate the body's immune system to recognize and attack cancer cells. This animation also describes how your doctor will evaluate whether immunotherapy is right for you, possible treatment side effects, and clinical trials. It's important to discuss all treatment options with your doctor or cancer care team, so you can make the best decisions that are right for you. Side effects of immunotherapy are often treated with prednisone, a drug that suppresses your immune system. Your immunotherapy will be stopped until the side effects clear up.


Join experts as they provide information and answer questions about small cell lung cancer to help patients and caregivers compare, discuss, and select treatment options with their doctor. See list below for topics discussed. Please note that this is a not an accredited activity.
Topics Discussed:
00:00 - Welcome and Introductions
02:09 - Cancer Staging
09:58 - Treatment
20:34 - Supportive Care to Improve Quality of Life
41:33 - New Treatments
47:14 - Clinical Trials
52:00 - Clinical Trials and Informational Sources Available to the Patient
1:02:07 - Q & A
1:20:26 - Closing Remarks
Question and Answer Session:
1:02:15 - What are some concerns about clinical trials?
1:03:35 - What level of fever do you ask patients to report? Do they call the office or go to the ER?
1:04:40 - Do you recommend prophylactic medications to prevent or manage neutropenia?
1:06:29 - How long after stopping immunotherapies should people monitor or report side effects?
1:08:00 - Who would you call regarding fatigue issues?
1:08:34 - Are there any immunotherapies available to people that have stable microsatellites and a low tumor mutational burden? Can these be successful?
1:09:42 - Is Lurbinectedin available in the EU?
1:10:03 - Biomarker testing is a standard of care in non-small cell lung cancer, but I've heard very little in small cell lung cancer. Is this something that is showing promise? If not, why not?
1:11:33 - How long after the last session of chemotherapy does it typically take for a CT scan to be performed to assess how the treatment performed?
1:12:36 - How long is immunotherapy recommended for to determine its effectiveness?
1:14:04 - What is meant by 'small cell lung cancer being a neuroendocrine tumor'? What is the mechanism or make up of the tumor to be given this classification?
1:15:56 - What are the characteristics for the 3% that survive 1 to 5 years?
1:16:44 - Are paraneoplastic syndromes checked for with bloodwork or symptoms only?
1:17:46 - Do you recommended 4 or 6 cycles for first line chemotherapy immunotherapy?
1:18:10 - When would clinical trials be recommended or introduced to a new patient that was recently diagnosed?
1:18:58 - Can an extensive stage small cell lung cancer patient receive preventative brain radiation?
The Patient Webinars: Small Cell Lung Cancer occurred in January 2022. This informational program was created in conjunction with the newly published NCCN Guidelines for Patients® for Small Cell Lung Cancer. (https://www.nccn.org/patientre....sources/patient-reso
The NCCN Guidelines for Patients (http://nccn.org/patientguidelines) are available to read and download for free online and via the NCCN Patient Guides for Cancer mobile app. Printed editions can be ordered from Amazon.com for a small fee.
NCCN Guidelines for Patients DO NOT replace the expertise and clinical judgment of the clinician.
Supporters:
This webinar is supported through the NCCN Foundation® and by a contribution from our corporate supporter: AstraZeneca.
________________________________________________________________
About NCCN Foundation®:
NCCN FOUNDATION® is a 501(c)3 organization founded by the National Comprehensive Cancer Network® (NCCN®)—a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education—to empower people living with cancer and advance oncology innovation. For more information or to make a donation, visit http://www.nccn.org/patients/foundation
________________________________________________________________
About NCCN:
The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, equitable, and accessible cancer care so all patients can live better lives. Visit https://www.nccn.org/ for more information.
Subscribe to our channel for the latest in cancer care: https://www.youtube.com/c/NCCN....video?sub_confirmati
Connect with us!
Twitter: https://twitter.com/NCCN
LinkedIn: https://www.linkedin.com/company/nccn/
Facebook: https://www.facebook.com/NCCNorg
Instagram: https://www.instagram.com/NCCNorg/


Learn more about lung cancer at http://www.YouAndLungCancer.com
Small cell lung cancer typically starts in the middle part of the chest and is often associated with breathing difficulties. Sometimes coughing occurs, or coughing up blood. Sometimes the tumor presses on one of the large veins that drain blood from the arms or head, resulting in swelling in the arms or sometimes swelling around the neck or the head.


Learn more about lung cancer at http://www.YouAndLungCancer.com
This animation explains how most patients with small cell lung cancer are treated. Most patients receive chemotherapy (or "chemo" for short) and radiation therapy. There are also supportive treatments to ease pain and discomfort; prevent and treat side effects; help you deal with stress and anxiety; and if you have not already done so, to help you stop smoking. Palliative treatments also exist to ease symptoms and improve quality of life.


Patient Points of View is a video series bringing individual stories to life by highlighting the uniqueness of each patient’s experience navigating their cancer journey.
In this video, hear from Lindy, who is living with small cell lung cancer. She opens up about the fears she faced when she was diagnosed and shares the support she felt from people like her granddaughter who stepped into the role of her care partner. Together, they learned to navigate the treatment landscape.
Explore other patient points of view: https://www.youtube.com/playli....st?list=PL4Tuh0XPkCh
Learn more about Amgen Oncology:
https://www.amgenoncology.com/
Find Amgen Oncology on the Web:
Twitter: https://bit.ly/3nGSj6Y
LinkedIn: https://bit.ly/3MhCe10
#cancer #cancerpatient #cancerjourney #Amgen #grandmother #granddaughter #cancerresearch #immunotherapy #patients #science #patientstory
© 2023 Amgen, Inc. All rights reserved.
Find Amgen on the Web:
Facebook: https://bit.ly/35Xf09E
Instagram: https://bit.ly/2SYnTKJ
Twitter: https://bit.ly/2SW2cLq
LinkedIn: https://bit.ly/2xWbS17